Published in PLoS Negl Trop Dis on March 10, 2009
Arthritogenic alphaviruses--an overview. Nat Rev Rheumatol (2012) 1.87
Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis (2013) 1.86
Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis (2013) 1.49
A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol (2010) 1.48
Chikungunya disease: infection-associated markers from the acute to the chronic phase of arbovirus-induced arthralgia. PLoS Negl Trop Dis (2012) 1.42
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis (2011) 1.41
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One (2011) 1.37
Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One (2009) 1.29
Chikungunya virus infection. Curr Infect Dis Rep (2011) 1.27
Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J Virol (2013) 1.26
ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog (2011) 1.26
Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med (2011) 1.24
Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012. PLoS Negl Trop Dis (2015) 1.24
Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis (2009) 1.18
Clinical forms of chikungunya in Gabon, 2010. PLoS Negl Trop Dis (2012) 1.07
Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage. PLoS One (2012) 1.06
Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther (2013) 1.05
Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia. F1000Res (2016) 1.02
Protective and Pathogenic Responses to Chikungunya Virus Infection. Curr Trop Med Rep (2015) 0.99
Animal Models of Chikungunya Virus Infection and Disease. J Infect Dis (2016) 0.96
Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus. Cell Host Microbe (2015) 0.95
A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol (2013) 0.92
Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus. J Immunol (2012) 0.91
Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies. J Clin Invest (2017) 0.89
Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology (2010) 0.87
A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection. J Infect Dis (2015) 0.86
Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis. Biomed Res Int (2013) 0.85
A Review of Chikungunya Virus-induced Arthralgia: Clinical Manifestations, Therapeutics, and Pathogenesis. Open Rheumatol J (2016) 0.85
Impact of Chikungunya on health related quality of life Chennai, South India. PLoS One (2012) 0.85
First Chikungunya Outbreak in Suriname; Clinical and Epidemiological Features. PLoS Negl Trop Dis (2016) 0.84
Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice. J Virol (2013) 0.84
Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice. J Virol (2014) 0.84
Chikungunya: epidemiology. F1000Res (2016) 0.84
Interventions for treating patients with chikungunya virus infection-related rheumatic and musculoskeletal disorders: A systematic review. PLoS One (2017) 0.82
Identical strength of the T cell responses against E2, nsP1 and capsid CHIKV proteins in recovered and chronic patients after the epidemics of 2005-2006 in La Reunion Island. PLoS One (2013) 0.81
Reemergence of Chikungunya virus in Indian Subcontinent. Indian J Virol (2010) 0.81
Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection. J Virol (2014) 0.80
γδ T Cells Play a Protective Role in Chikungunya Virus-Induced Disease. J Virol (2015) 0.80
Nonhuman Primate Models of Chikungunya Virus Infection and Disease (CHIKV NHP Model). Pathogens (2015) 0.78
Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells. PLoS Pathog (2015) 0.77
Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells. J Virol (2016) 0.77
Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence. Cell Rep (2016) 0.76
Unusual presentation of chikungunya virus infection with concomintant erysipelas in a returning traveler from the Caribbean: a case report. Open Forum Infect Dis (2014) 0.76
Molecular Virologic and Clinical Characteristics of a Chikungunya Fever Outbreak in La Romana, Dominican Republic, 2014. PLoS Negl Trop Dis (2016) 0.75
Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate. PLoS Negl Trop Dis (2016) 0.75
Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes. BMC Musculoskelet Disord (2014) 0.75
Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design. MBio (2017) 0.75
Clinical Manifestations Associated with Peripheral Joint Involvement in Patients with Acute Chikungunya Virus Infection. Am J Trop Med Hyg (2017) 0.75
Osteoblasts from osteoarthritis patients show enhanced susceptibility to Ross River virus infection associated with delayed type I interferon responses. Virol J (2014) 0.75
Chikungunya Fever Cases Identified in the Veterans Health Administration System, 2014. PLoS Negl Trop Dis (2016) 0.75
Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201). Antiviral Res (2014) 0.75
Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World. West J Emerg Med (2016) 0.75
Molecular Mimicry between Chikungunya Virus and Host Components: A Possible Mechanism for the Arthritic Manifestations. PLoS Negl Trop Dis (2017) 0.75
Novel Lesions of Bones and Joints Associated with Chikungunya Virus Infection in Two Mouse Models of Disease: New Insights into Disease Pathogenesis. PLoS One (2016) 0.75
Persistent Arthralgia Associated with Chikungunya Virus Outbreak, US Virgin Islands, December 2014-February 2016. Emerg Infect Dis (2017) 0.75
MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE. J Virol (2017) 0.75
Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques. PLoS Negl Trop Dis (2017) 0.75
Community participation in mosquito breeding site control: an interdisciplinary mixed methods study in Curaçao. Parasit Vectors (2017) 0.75
Chikungunya virus: clinical aspects and treatment - A Review. Mem Inst Oswaldo Cruz (2017) 0.75
The Range of Neurological Complications in Chikungunya Fever. Neurocrit Care (2017) 0.75
Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants. PLoS Pathog (2017) 0.75
Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet (2007) 10.81
Chikungunya, an epidemic arbovirosis. Lancet Infect Dis (2007) 7.87
Critical review of the vector status of Aedes albopictus. Med Vet Entomol (2004) 6.28
Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol (2007) 6.16
An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans R Soc Trop Med Hyg (1955) 4.94
A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg (2007) 4.18
Chikungunya outbreaks caused by African genotype, India. Emerg Infect Dis (2006) 3.97
Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis (2007) 3.87
Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: identification of a new central African strain. J Med Virol (2004) 2.94
Emerging viral diseases of Southeast Asia and the Western Pacific. Emerg Infect Dis (2001) 2.91
Chikungunya infection--an emerging disease in Malaysia. Southeast Asian J Trop Med Public Health (2001) 2.69
Aedes albopictus as an epidemic vector of chikungunya virus: another emerging problem? Lancet Infect Dis (2006) 2.61
Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg (2008) 2.53
Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) (2007) 2.48
Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis (2007) 2.44
Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J (1983) 2.38
Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis (2008) 2.31
Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One (2008) 2.14
Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am J Trop Med Hyg (2007) 2.09
Outbreak of dengue and Chikungunya fevers, Toamasina, Madagascar, 2006. Emerg Infect Dis (2008) 2.02
Chikungunya viral arthropathy: a clinical description. J Rheumatol (1980) 1.86
Arthritides caused by mosquito-borne viruses. Annu Rev Med (1982) 1.73
Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust (2002) 1.71
Prolonged arthritis associated with sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) (2000) 1.52
Current status of Aedes albopictus and Aedes atropalpus in Italy. J Am Mosq Control Assoc (1999) 1.46
Chikungunya fever, Mauritius, 2006. Emerg Infect Dis (2008) 1.46
Imported cases of chikungunya in metropolitan France: update to June 2006. Euro Surveill (2006) 1.43
Rheumatoid arthritic syndrome after chikungunya fever. S Afr Med J (1979) 1.30
Acute symptoms and sequelae of Ross River virus infection in South-Western Australia: a follow-up study. Clin Diagn Virol (1995) 1.22
Determining mild, moderate, and severe pain equivalency across pain-intensity tools in nursing home residents. J Rehabil Res Dev (2007) 1.21
Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. Med J Aust (2002) 1.12
[Chikungunya virus outbreak in Senegal in 1996 and 1997]. Bull Soc Pathol Exot (1999) 1.06
Clinical and laboratory manifestations of Sindbis virus infection: prospective study, Finland, 2002-2003. J Infect Dis (2005) 1.06
[Exotic viral arthritis: role of alphavirus]. Med Trop (Mars) (2004) 0.93
Ross River virus infection on the North Coast of New South Wales. Aust N Z J Public Health (1996) 0.81
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med (2004) 4.47
A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg (2007) 4.18
Chikungunya disease outbreak, Reunion Island. Emerg Infect Dis (2006) 2.78
Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics (2009) 2.76
Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr (2007) 2.66
Does monastic life predispose to the risk of Saint Anthony's fire (herpes zoster)? Clin Infect Dis (2011) 2.56
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med (2010) 2.47
Mortality in 13 French cities during the August 2003 heat wave. Am J Public Health (2004) 2.36
Impact of the 2003 heatwave on all-cause mortality in 9 French cities. Epidemiology (2006) 2.33
Treatment of Ebola virus disease. Intensive Care Med (2014) 2.33
Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One (2008) 2.14
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. N Engl J Med (2016) 2.09
France's heat health watch warning system. Int J Biometeorol (2005) 2.06
The relation between temperature, ozone, and mortality in nine French cities during the heat wave of 2003. Environ Health Perspect (2006) 2.06
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012. Clin Infect Dis (2014) 1.80
Rift Valley fever, Mayotte, 2007-2008. Emerg Infect Dis (2009) 1.72
Interventions for vitiligo. Cochrane Database Syst Rev (2015) 1.57
Two patients with imported acute neuroschistosomiasis due to Schistosoma mansoni. J Travel Med (2010) 1.43
[Retrospective analysis of 107 imported adult cases of malaria. Experience report of uncomplicated falciparum malaria treatment in adults with oral atovaquone-proguanil]. Presse Med (2006) 1.43
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis (2011) 1.41
The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One (2010) 1.34
Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One (2009) 1.29
Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet (2010) 1.25
Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med (2011) 1.24
Outbreak of Chikungunya fever in Mayotte, Comoros archipelago, 2005-2006. Trans R Soc Trop Med Hyg (2008) 1.22
Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol (2009) 1.22
Ocular lesions associated with malaria in children in Mali. Am J Trop Med Hyg (2002) 1.22
Evaluation of FRET real-time PCR assay for rapid detection and differentiation of Plasmodium species in returning travellers and migrants. Malar J (2008) 1.21
Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis (2009) 1.18
Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med (2002) 1.17
Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP. J Invest Dermatol (2010) 1.14
Ebola: Europe-Africa research collaborations. Lancet Infect Dis (2015) 1.12
Quinine-resistant malaria in traveler returning from Senegal, 2007. Emerg Infect Dis (2010) 1.11
Quercetin induces apoptosis of Trypanosoma brucei gambiense and decreases the proinflammatory response of human macrophages. Antimicrob Agents Chemother (2004) 1.09
Neglected diseases in the news: a content analysis of recent international media coverage focussing on leishmaniasis and trypanosomiasis. PLoS Negl Trop Dis (2008) 1.09
Field evaluation of clinical features during chikungunya outbreak in Mayotte, 2005-2006. Trop Med Int Health (2010) 1.08
Treatment of generalized vitiligo with anti-TNF-α Agents. J Drugs Dermatol (2012) 1.08
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol (2011) 1.08
Active trachoma among children in Mali: Clustering and environmental risk factors. PLoS Negl Trop Dis (2010) 1.06
Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther (2013) 1.05
Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar J (2006) 1.04
Therapeutic and preventive properties of quercetin in experimental arthritis correlate with decreased macrophage inflammatory mediators. Biochem Pharmacol (2006) 1.03
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in urban health facilities in Yaoundé, central province, Cameroon. Malar J (2009) 1.03
Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharan Africa: Cost-effectiveness analysis from the perspective of the French national health insurance system. Health Policy (2008) 1.03
Severe bullous skin lesions associated with Chikungunya virus infection in small infants. Eur J Pediatr (2009) 1.03
Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests. Malar J (2012) 0.99
Treatment of malaria from monotherapy to artemisinin-based combination therapy by health professionals in rural health facilities in southern Cameroon. Malar J (2009) 0.98
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study. Clin Infect Dis (2004) 0.96
Chikungunya Virus Infections. N Engl J Med (2015) 0.96
Skin features accompanying imported human African trypanosomiasis: hemolymphatic Trypanosoma gambiense infection among two French expatriates with dermatologic manifestations. J Travel Med (2007) 0.96
Compliance, safety, and effectiveness of fixed-dose artesunate-amodiaquine for presumptive treatment of non-severe malaria in the context of home management of malaria in Madagascar. Am J Trop Med Hyg (2012) 0.96
Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res (2008) 0.96
Buruli ulcer in long-term traveler to Senegal. Emerg Infect Dis (2009) 0.95
Chikungunya-related fatality rates, Mauritius, India, and Reunion Island. Emerg Infect Dis (2008) 0.94
Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum. Malar J (2012) 0.94
Trichiasis and geoclimatic factors in Mali. Trans R Soc Trop Med Hyg (2007) 0.93
Cutaneous manifestations in Costello and cardiofaciocutaneous syndrome: report of 18 cases and literature review. Pediatr Dermatol (2013) 0.93
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Res (2009) 0.93
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Malar J (2013) 0.93
Risks associated with the microbiological quality of bodies of fresh and marine water used for recreational purposes: summary estimates based on published epidemiological studies. Arch Environ Health (2003) 0.93
Imported cutaneous melioidosis in traveler, Belgium. Emerg Infect Dis (2007) 0.92
Factors associated with morbidity during the 2003 heat wave in two population-based cohorts of elderly subjects: PAQUID and Three City. Eur J Epidemiol (2008) 0.91
Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study. PLoS One (2013) 0.91
Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab (2014) 0.91
Cluster of eosinophilic meningitis attributable to Angiostrongylus cantonensis infection in French policemen troop returning from the Pacific Islands. Travel Med Infect Dis (2008) 0.90
IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway. PLoS One (2011) 0.90
Evaluation of the impact of a breast cancer awareness program in rural Ghana: a cross-sectional survey. Int J Cancer (2013) 0.89
Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. Pigment Cell Melanoma Res (2015) 0.89
Functional MC1R-gene variants are associated with increased risk for severe photoaging of facial skin. J Invest Dermatol (2009) 0.89
Clinical phenotype of scabies by age. Pediatrics (2014) 0.89
Prevalence of inherited ichthyosis in France: a study using capture-recapture method. Orphanet J Rare Dis (2014) 0.89
Seroepidemiology of Dengue virus in Mayotte, Indian Ocean, 2006. PLoS One (2010) 0.88
An imported case of Chikungunya fever from Madagascar: use of the sentinel traveller for detecting emerging arboviral infections in tropical and European countries. Travel Med Infect Dis (2008) 0.88
Tickborne encephalitis, southwestern France. Emerg Infect Dis (2007) 0.87
Availability of antimalarial drugs and evaluation of the attitude and practices for the treatment of uncomplicated malaria in bangui, central african republic. J Trop Med (2010) 0.87
Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway. Biochem Pharmacol (2004) 0.86
Type I interferon signature in the initiation of the immune response in vitiligo. Pigment Cell Melanoma Res (2014) 0.86
Prevalence of undernutrition and vitamin A deficiency in the Dogon Region, Mali. J Am Coll Nutr (2002) 0.85